학술논문
Combined treatment with a gastric inhibitory polypeptide receptor antagonist and a peptidyl peptidase-4 inhibitor improves metabolic abnormalities in diabetic mice.
Document Type
Article
Author
Source
Journal of International Medical Research; Jan2021, Vol. 49 Issue 1, p1-12, 12p
Subject
Language
ISSN
03000605